Strategic Advisors LLC Has $1.53 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Strategic Advisors LLC lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 19,557 shares of the company’s stock after selling 3,349 shares during the quarter. Strategic Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,529,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of GEHC. State Street Corp increased its position in GE HealthCare Technologies by 7.8% during the third quarter. State Street Corp now owns 18,615,890 shares of the company’s stock worth $1,747,101,000 after buying an additional 1,347,114 shares during the last quarter. Geode Capital Management LLC increased its position in GE HealthCare Technologies by 7.2% during the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company’s stock worth $1,026,898,000 after buying an additional 733,819 shares during the last quarter. Van ECK Associates Corp increased its position in GE HealthCare Technologies by 107.3% during the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company’s stock worth $378,520,000 after buying an additional 2,506,417 shares during the last quarter. D1 Capital Partners L.P. acquired a new position in GE HealthCare Technologies during the third quarter worth approximately $268,159,000. Finally, Charles Schwab Investment Management Inc. increased its position in GE HealthCare Technologies by 12.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company’s stock worth $254,422,000 after buying an additional 290,019 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.4 %

Shares of GEHC stock opened at $92.21 on Monday. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12. The stock has a market cap of $42.13 billion, a P/E ratio of 25.33, a price-to-earnings-growth ratio of 2.93 and a beta of 1.15. The stock has a 50 day simple moving average of $84.03 and a 200 day simple moving average of $85.54. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th were paid a dividend of $0.035 per share. The ex-dividend date was Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on GEHC. Citigroup boosted their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday. Wells Fargo & Company upped their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.